These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 28274154)

  • 1. Investigational drugs for the treatment of cervical cancer.
    Barra F; Lorusso D; Leone Roberti Maggiore U; Ditto A; Bogani G; Raspagliesi F; Ferrero S
    Expert Opin Investig Drugs; 2017 Apr; 26(4):389-402. PubMed ID: 28274154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigational drugs for head and neck cancer.
    Bossi P; Alfieri S
    Expert Opin Investig Drugs; 2016 Jul; 25(7):797-810. PubMed ID: 27054910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The safety and efficacy of bevacizumab in the treatment of patients with recurrent or metastatic cervical cancer.
    Minion LE; Tewari KS
    Expert Rev Anticancer Ther; 2017 Mar; 17(3):191-198. PubMed ID: 27748633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigational drugs for recurrent or primary advanced metastatic cervical cancer: what is in the clinical development pipeline?
    Vergote I; Ray-Coquard I; Lorusso D; Oaknin A; Cibula D; Van Gorp T
    Expert Opin Investig Drugs; 2023 Mar; 32(3):201-211. PubMed ID: 36803278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Promising investigational drug candidates in phase I and phase II clinical trials for mesothelioma.
    Guazzelli A; Bakker E; Tian K; Demonacos C; Krstic-Demonacos M; Mutti L
    Expert Opin Investig Drugs; 2017 Aug; 26(8):933-944. PubMed ID: 28679291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunotherapy and targeted therapy for cervical cancer: an update.
    Menderes G; Black J; Schwab CL; Santin AD
    Expert Rev Anticancer Ther; 2016; 16(1):83-98. PubMed ID: 26568261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cervical cancer: are there potential new targets? An update on preclinical and clinical results.
    Tomao F; Di Tucci C; Imperiale L; Boccia SM; Marchetti C; Palaia I; Muzii L; Panici PB
    Curr Drug Targets; 2014; 15(12):1107-20. PubMed ID: 25300780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of patients with recurrent/advanced cervical cancer beyond first line platinum regimens: Where do we stand? A literature review.
    Boussios S; Seraj E; Zarkavelis G; Petrakis D; Kollas A; Kafantari A; Assi A; Tatsi K; Pavlidis N; Pentheroudakis G
    Crit Rev Oncol Hematol; 2016 Dec; 108():164-174. PubMed ID: 27931835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An overview of early investigational therapies for chemoresistant ovarian cancer.
    Marchetti C; Ledermann JA; Benedetti Panici P
    Expert Opin Investig Drugs; 2015; 24(9):1163-83. PubMed ID: 26206420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigational therapies for squamous cell lung cancer: from animal studies to phase II trials.
    Shum E; Wang F; Kim S; Perez-Soler R; Cheng H
    Expert Opin Investig Drugs; 2017 Apr; 26(4):415-426. PubMed ID: 28277882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Targeted therapy in locally and metastatic recurrent cervical cancers].
    Geiss R; De La Motte Rouge T; Dubot C; Leary A; Lhommé C; Pautier P; Scholl S; Rodrigues MJ
    Bull Cancer; 2014; 101(7-8):748-55. PubMed ID: 25091657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beyond Chemotherapy: An Overview and Review of Targeted Therapy in Cervical Cancer.
    Crafton SM; Salani R
    Clin Ther; 2016 Mar; 38(3):449-58. PubMed ID: 26926322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigational drugs for nasopharyngeal carcinoma.
    Ma BBY; Hui EP; Chan ATC
    Expert Opin Investig Drugs; 2017 Jun; 26(6):677-685. PubMed ID: 28446055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An overview of experimental and investigational multikinase inhibitors for the treatment of metastatic colorectal cancer.
    Lee YC; Michael M; Zalcberg JR
    Expert Opin Investig Drugs; 2015; 24(10):1307-20. PubMed ID: 26212373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigational new drugs for brain cancer.
    Staedtke V; Bai RY; Laterra J
    Expert Opin Investig Drugs; 2016 Aug; 25(8):937-56. PubMed ID: 27170161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emerging drugs for the treatment of cervical cancer.
    Serrano-Olvera A; Cetina L; Coronel J; Dueñas-González A
    Expert Opin Emerg Drugs; 2015 Jun; 20(2):165-82. PubMed ID: 25578210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigational drugs for treating anal cancer and future perspectives.
    Bustamante L; Frakes J; Hoffe S; Kim R
    Expert Opin Investig Drugs; 2016; 25(1):51-62. PubMed ID: 26560877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting angiogenesis in endometrial cancer - new agents for tailored treatments.
    Papa A; Zaccarelli E; Caruso D; Vici P; Benedetti Panici P; Tomao F
    Expert Opin Investig Drugs; 2016; 25(1):31-49. PubMed ID: 26560489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigational therapies for Ewing sarcoma: a search without a clear finding.
    Vornicova O; Bar-Sela G
    Expert Opin Investig Drugs; 2016 Jun; 25(6):679-86. PubMed ID: 26988130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bevacizumab for the treatment of cervical cancer.
    Bizzarri N; Ghirardi V; Alessandri F; Venturini PL; Valenzano Menada M; Rundle S; Leone Roberti Maggiore U; Ferrero S
    Expert Opin Biol Ther; 2016; 16(3):407-19. PubMed ID: 26796332
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.